Todd Meyerrose is a co-founder of Lexent Bio, which focuses on liquid biopsy detection for treatment response, currently operating since 2016. As a founding partner at BioMed Ventures since 2015, Todd has invested in multiple companies across various sectors, including precision medicine and oncology. In addition to entrepreneurial roles, Todd serves as a consulting associate professor at Stanford University, co-directing the Biotechnology Business and Finance course. Advisory positions have been held at ixlayer and Genome Medical, while Todd also maintains active investments in several biotech startups. Educationally, Todd holds a PhD in Molecular Cell Biology from Washington University School of Medicine and a PhD in Craniofacial Biology and Development from the University of Southern California, alongside a BS in Biology from the University of Kentucky.
This person is not in any teams
This person is not in any offices